GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B5062 Endothelin 3 (human, rat)Summary: Endogenous neuropeptide with selectivity for the putative ETC endothelin receptor -
B5064 Somatostatin 1-28Summary: Somatostatin receptor agonist -
B5065 [Leu31,Pro34]-Neuropeptide Y (porcine)Summary: High affinity neuropeptide Y Y1 receptor agonist -
B5066 CGRP 8-37 (rat)Summary: Peptide antagonist for CGRP1 receptors -
B5069 Sarafotoxin S6bSummary: non-selective endothelin receptor agonist -
B5070 Sarafotoxin S6cSummary: Highly selective ETB endothelin receptor agonist -
B5073 CGRP 8-37 (human)Summary: Peptide antagonist for CGRP1 receptors -
B5074 VIP (guinea pig)Summary: Neuropeptide with many biological actions -
B5075 PACAP 1-27Summary: endogenous neuropeptide, stimulator of adenylate cyclase -
B5076 α-helical CRF 9-41Summary: Antagonist of corticotropin releasing factor receptor

